Evidence map›Paper›PMID 33047169›Full record

ArticleDiabetologia2020

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).

Othmar Moser, Michael C Riddell, Max L Eckstein, Peter Adolfsson, Rémi Rabasa-Lhoret, Louisa van den Boom, Pieter Gillard, Kirsten Nørgaard, Nick S Oliver, Dessi P Zaharieva and 20 more

Open access · bronzeAbstract readConsensus Statement
PubMed Publisher
In one paragraph

Article in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 3 pooled it
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 3 syntheses or guidelines pooled it, 201 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Review
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 20 institutions in 14 countries.

Othmar MoserDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 2, 8036, Graz, Austria. Othmar.moser@medunigraz.at.ORCID 0000-0002-1661-0685
Michael C RiddellSchool of Kinesiology and Health Science, York University, Toronto, ON, Canada.ORCID 0000-0001-6556-7559
Max L EcksteinDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 2, 8036, Graz, Austria.ORCID 0000-0003-0320-8408
Peter AdolfssonDepartment of Pediatrics, The Hospital of Halland, Kungsbacka, Sweden.ORCID 0000-0001-7615-9737
Rémi Rabasa-LhoretInstitut de Recherches Cliniques de Montréal, Montréal, QC, Canada.ORCID 0000-0003-4706-5170
Louisa van den BoomDivision of Pediatric Diabetology, DRK Children's Hospital, Siegen, Germany.ORCID 0000-0003-4823-2620
Pieter GillardDepartment of Endocrinology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0001-9111-4561
Kirsten NørgaardSteno Diabetes Center Copenhagen, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-1620-8271
Nick S OliverDepartment of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College, London, London, UK.ORCID 0000-0003-3525-3633
Dessi P ZaharievaDepartment of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-9374-8469
Tadej BattelinoDepartment of Paediatric Endocrinology, Diabetes and Metabolic Diseases, UMC - University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.ORCID 0000-0002-0273-4732
Carine de BeaufortDepartment of Pediatric Diabetes and Endocrinology, Centre Hospitalier Luxembourg, Luxembourg, Luxembourg.ORCID 0000-0003-4310-6799
Richard M BergenstalInternational Diabetes Center, Minneapolis, MN, USA.ORCID 0000-0002-9050-5584
Bruce BuckinghamDepartment of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-4581-4887
Eda CengizDepartment of Pediatrics, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-7992-9506
Asma DeebPaediatric Endocrinology Division, Shaikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.ORCID 0000-0003-4090-4672
Tim HeiseProfil, Neuss, Germany.ORCID 0000-0003-2116-1412
Simon HellerDepartment of Oncology & Metabolism, The Medical School, University of Sheffield, Sheffield, UK.ORCID 0000-0002-2425-9565
Aaron J KowalskiJDRF, New York, NY, USA.ORCID 0000-0002-0979-5343
Lalantha LeelarathnaManchester Diabetes Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0001-9602-1962
Chantal MathieuDepartment of Endocrinology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0002-4055-5233
Christoph StettlerDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.ORCID 0000-0003-1691-6059
Martin TauschmannDepartment of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-2305-2490
Hood ThabitManchester Diabetes Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0001-6076-6997
Emma G WilmotDiabetes Department, Royal Derby Hospital, University Hospitals of Derby and Burton NHSFT, Derby, UK.ORCID 0000-0002-8698-6207
Harald SourijDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 2, 8036, Graz, Austria.ORCID 0000-0003-3510-9594
Carmel E SmartSchool of Health Sciences, University of Newcastle, Callaghan, NSW, Australia.ORCID 0000-0003-3104-8800
Peter G JacobsDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.ORCID 0000-0001-9897-4783
Richard M BrackenApplied Sport, Technology, Exercise and Medicine Research Centre (A-STEM), College of Engineering, Swansea University, Swansea, UK.ORCID 0000-0002-6986-6449
Julia K MaderDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 2, 8036, Graz, Austria.ORCID 0000-0001-7854-4233
Medical University of Graz · ATKU Leuven · BEManchester Academic Health Science Centre · GBStanford University · USBahçeşehir University · TRBreakthrough T1D · USCentre Hospitalier de Luxembourg · LUDiabetes Canada · CAHallands sjukhus Kungsbacka · SEImperial College London · GBJohn Hunter Children's Hospital · AUMedical University of Vienna · ATOregon Health & Science University · USProfil Institute for Metabolic Research · DESheffield Teaching Hospitals NHS Foundation Trust · GBSheikh Shakhbout Medical City · AESwansea University · GBUniversity of Bern · CHUniversity of Copenhagen · DKUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, to some extent, on the intensity and duration of the type of exercise. Understandably, fear of hypoglycaemia is one of the strongest barriers to incorporating exercise into daily life. Risk of hypoglycaemia during and after exercise can be lowered when insulin-dose adjustments are made and/or additional carbohydrates are consumed. Glycaemic management during exercise has been made easier with continuous glucose monitoring (CGM) and intermittently scanned continuous glucose monitoring (isCGM) systems; however, because of the complexity of CGM and isCGM systems, both individuals with type 1 diabetes and their healthcare professionals may struggle with the interpretation of given information to maximise the technological potential for effective use around exercise (i.e. before, during and after). This position statement highlights the recent advancements in CGM and isCGM technology, with a focus on the evidence base for their efficacy to sense glucose around exercise and adaptations in the use of these emerging tools, and updates the guidance for exercise in adults, children and adolescents with type 1 diabetes. Graphical abstract.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1ExerciseHumansQuality of LifeBlood GlucoseAdolescentsAdultsCGMChildrenContinuous glucose monitoringExercisePhysical activityPosition statementType 1 diabetes

Identifiers

PMID33047169
OpenAlexW3092224625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.